Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Aunsmo RH, Strand BH, Bergh S, Hansen T, Kivimäki M, Köhler S, Krokstad S, Langballe EM, Livingston G, Matthews FE, Selbæk G(2025) Loneliness trajectories and dementia risk: Insights from the HUNT cohort study Alzheimers Dement (Amst), 17(3), e70154 DOI 10.1002/dad2.70154, PubMed 40735047
Fjell AM, Rogeberg O, Sørensen Ø, Amlien IK, Bartrés-Faz D, Brandmaier AM, Cattaneo G, Düzel S, Grydeland H, Henson RN, Kühn S, Lindenberger U, Lyngstad TH, Mowinckel AM, Nyberg L, Pascual-Leone A, Solé-Padullés C, Sneve MH, Solana J, Strømstad M, Watne LO, Walhovd KB, Vidal-Piñeiro D(2025) Reevaluating the role of education on cognitive decline and brain aging in longitudinal cohorts across 33 Western countries Nat Med(in press) DOI 10.1038/s41591-025-03828-y, PubMed 40721513
Saatvedt O, Furunes H, Schubert PF, Fidje Ø, Molund M(2025) MRI Evaluation of Ligamentous Injury in Weightbearing-Stable Suprasyndesmotic Ankle Fractures: A Prospective Observational Study Foot Ankle Int, 10711007251352549(in press) DOI 10.1177/10711007251352549, PubMed 40721353